JPMorgan U.S. Tech Leaders ETF (NASDAQ:JTEK) Sets New 52-Week High – Time to Buy?

JPMorgan U.S. Tech Leaders ETF (NASDAQ:JTEK)’s stock price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $84.47 and last traded at $84.20, with a volume of 31360 shares trading hands. The stock had previously closed at $83.29.

JPMorgan U.S. Tech Leaders ETF Price Performance

The firm has a market cap of $1.18 billion, a PE ratio of 47.95 and a beta of 1.82. The company has a 50 day moving average price of $79.55 and a 200 day moving average price of $72.75.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Comerica Bank acquired a new position in JPMorgan U.S. Tech Leaders ETF in the 4th quarter valued at about $38,000. Briaud Financial Planning Inc acquired a new position in shares of JPMorgan U.S. Tech Leaders ETF in the fourth quarter valued at approximately $57,000. Wagner Wealth Management LLC lifted its stake in shares of JPMorgan U.S. Tech Leaders ETF by 22.0% during the fourth quarter. Wagner Wealth Management LLC now owns 2,264 shares of the company’s stock valued at $171,000 after buying an additional 409 shares during the period. Sanctuary Advisors LLC acquired a new stake in JPMorgan U.S. Tech Leaders ETF during the third quarter worth approximately $193,000. Finally, Indie Asset Partners LLC grew its stake in JPMorgan U.S. Tech Leaders ETF by 7.3% in the 3rd quarter. Indie Asset Partners LLC now owns 3,296 shares of the company’s stock worth $226,000 after acquiring an additional 225 shares during the period.

JPMorgan U.S. Tech Leaders ETF Company Profile

The JPMorgan U.S. Tech Leaders ETF JPMorgan U.S. Tech Leaders ETF (JTEK) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that identifies US equities that are perceived as leaders in technology and technology-enabled industries such as engineering & construction, entertainment, biotechnology, pharmaceuticals, REITs, and energy-alternate sources.